Hematology Update
April 8-9, 2017

Presented by Seattle Cancer Care Alliance

Course Description

This two-day program will cover evidence-based guidelines, recommendations and recent advances regarding therapeutic options for patients with benign and malignant hematologic disorders. At the end of the course, physicians will leave with a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for common benign and malignant hematologic disorders.

CME/CE Credit Designation Statement

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Gold_school_logo master

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top